EANO Meeting - Friday, September 16, 2022
Note that the programme is subject to change and will be continuously updated. Speaker and presentation details will be published in due course.
All times below refer to Central European Summer Time (CEST).
08:00-09:00 hrs
Chairs: tba
ME01.1 Medical Decision Making
Hilary Bekker, United Kingdom, Denmark
ME01.2 Decision aids for clinical encounters
Cecilia Pompili, Italy
ME01.3 Decisional needs in patients with recurrent high-grade glioma and their families
Helle Soerensen von Essen, Denmark
Chair: tba
ME02.1 Physiologic and metabolic MR imaging in brain gliomas: towards a virtual biopsy?
Janine Lupo, United States
ME02.2 Exploring glioma metabolism using Hyperpolarized 13C MRI
Fulvio Zaccagna, Italy
ME02.3 Surveillance metabolic Mr imaging in conventional and new moecular gliomas treatment regimens
Sotirios Bisdas, United Kingdom
Chairs: tba
ME03.1 Strategies to expand tumor-specific T cells (Medulloblastoma)
Catherine Flores, United States
ME03.2 TBC
John Sampson, United States
ME03.3 Clinical us of CAR-NK cells in glioblastoma
Joachim Steinbach, Germany
09:00-09:15 hrs | BREAK
09:15-10:45 hrs
Chairs: tba
OS01.1 Application of serum spectroscopy and pathway to implementation in clinical practice
Paul Brennan, United Kingdom
OS01.2 Serum DNA methylation profiles in diagnosis and follow up of adult glioma
Houtan Noushmehr, United States
OS01.3 Tumour DNA in CSF as a biomarker in glioma
Alexandra Miller, United States
OS01.4 pre-diagnostic metabolic biomarkers in glioma
Beatrice Melin, Sweden
JS02.1 Overview of EORTC Brain Tumor Group studies
Matthias Preusser, Austria
Chair EORTC Brain Tumor Group
JS02.2 tba
Susan Chang, United States
Editor-in-Chief Neuro-Oncology Journal
JS02.3 tba
Gelareh Zadeh, Canada
Editor-in-Chief Neuro-Oncology Advances Journal
JS02.4 tba
Martin Taphoorn, Netherlands
Editor-in-Chief Neuro-Oncology Practice Journal
Chairs: tba
OS02.1 Complexity of symptom science research
Karin Piil, Denmark
OS02.2 Fatigue and insomnia
Katrine Loeppenthin, Denmark
OS02.3 Affective symptoms, anxiety, depression
Pernille Bidstrup, Denmark
OS02.4 Systems approaches to symptom management: a palliative care perspective
Anthony Byrne, United Kingdom
10:45-11:15 hrs | COFFEE BREAK
11:15-13:00 hrs
Matthias Preusser, Austria
President EANO & EANO Meeting 2022
Michael Platten, Germany
Chair EANO Scientific Committee
Chairs: tba
PL01.1 How artificial intelligence is changing (Neuro) Oncology
Regina Barzilay, United States
PL01.2 tbc
Raul Rabadán, United States
13:00-14:30 hrs | LUNCH BREAK
13:15-14:15 hrs
Chairs: tba
WS01.1 Crash course immunology
Leila Akkari, Netherlands
WS01.2 Did the checkmate studies really fail?
Anna Berghoff, Austria
WS01.3 How to sensitize glioblastoma to immunotherapy
Michael Platten, Germany
Chairs: tba
WS02.1 Evidence around adaptations made in response to the pandemic
Martin Klein, Netherlands
WS02.2 Differences between clinical and research practices
Claudia Panciroli, Spain
WS02.3 Advances: online unsupervised cognitive testing
Sanne Schagen, Netherlands
14:30-16:00 hrs
Chairs: tba
KS01.1 Recurrent glioblastoma: Treatment perspective
Tracy Batchelor, United States
KS01.2 Recurrent glioblastoma: Imaging
Philipp Lohmann, Germany
KS01.3 Recurrent glioblastoma: Molecular pathology
Pim French, Netherlands
Chairs: tba
OS03.1 Melanma brain metastases (symptomatic and asymptomatic)
Caroline Robert, France
OS03.2 The metabolic adaptation evoked by arginine enhances the effect of radiation in brain metastases (Clinical-Translational/ Radiation/ Metabolism)
Leandro Cerchietti, United States
OS03.3 Antibody drug Conjugates anti-HER2+ in brain metastasis
Matthias Preusser, Austria
Chairs: Emilie Le Rhun, Susan Short
OS04.1 Positive Discrimination Survey
Emilie Le Rhun, Switzerland
OS04.2 Comorbidities and physical vulnerability
Enrico Franceschi, Italy
OS04.3 Psychological and cognitive vulnerability
Willemijn van Erp, Netherlands
OS04.4 Wrap-up and EANO Disparity Statement
Susan Short, United Kingdom
Panelists:
Florien Boele, United Kingdom
Ally Rooney, United Kingdom
Linda Dirven, Netherlands
Andreas Luft, Switzerland
16:00-16:15 hrs | BREAK
16:15-17:45 hrs
Chairs: tba
KS02.1 Person-centred care – concept, implications for practice, and challenges for implementation
Brendan Mccormack, United Kingdom
KS02.2 Implementation science, informing policy decisions
Tanja Stamm, Austria
KS02.3 Patient-reported and experience measures
Linda Dirven, Netherlands
KS02.4 Discrepancies between healthcare professionals’ and patients’ preferences
Helen Bulbeck, United Kingdom
Chairs: tba
JS03.1 NF1 – models and therapeutic approaches
David Gutmann, United States
JS03.2 TSC-related tumors – novel therapies
Roberta Ruda, Italy
JS03.3 Management of NF2-related tumors
Michel Kalamarides, France
JS03.4 Mechanisms of glioma inheritance
Melissa Bondy, United States
Chairs: tba
OS05.1 Sex-specific myeloid cell education in the immune microenvironment
Bożena Kamińska-Kaczmarek, Poland
OS05.2 Neutrophils in the immune microenvironment and in brain metastasis
Dihua Yu, United States
OS05.3 Dysfunctional antigen presentation in the immune microenvironment
Lisa Sevenich, Germany
